RESUMO
BACKGROUND: EMIT-1 is a national, observational, single-arm trial designed to assess the value of the Prosigna, Prediction Analysis of Microarray using the 50 gene classifier (PAM50)/Risk of Recurrence (ROR), test as a routine diagnostic tool, examining its impact on adjuvant treatment decisions, clinical outcomes, side-effects and cost-effectiveness. Here we present the impact on treatment decisions. PATIENTS AND METHODS: Patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative pT1-pT2 lymph node-negative early breast cancer (EBC) were included. The Prosigna test and standard histopathology assessments were carried out. Clinicians' treatment decisions were recorded before (pre-Prosigna) and after (post-Prosigna) the Prosigna test results were disclosed. RESULTS: Of 2217 patients included, 2178 had conclusive Prosigna results. The pre-Prosigna treatment decisions were: no systemic treatment (NT) in 27% of patients, endocrine treatment alone (ET) in 38% and chemotherapy (CT) followed by ET (CT + ET) in 35%. Post-Prosigna treatment decisions were 25% NT, 51% ET and 24% CT + ET, respectively. Adjuvant treatment changed in 28% of patients, including 21% change in CT use. Among patients assigned to CT + ET pre-Prosigna, 45% were de-escalated to ET post-Prosigna. Of patients assigned to ET, 12% were escalated to CT + ET and 8% were de-escalated to NT; of those assigned to NT, 18% were escalated to ET/CT + ET. CT was more frequently recommended for patients aged ≤50 years. In the subgroup with pT1c-pT2 G2 and intermediate Ki67 (0.5-1.5× local laboratory median Ki67 score), the pre-Prosigna CT treatment decision varied widely across hospitals (3%-51%). Post-Prosigna, the variability of CT use was markedly reduced (8%-24%). The correlation between Ki67 and ROR score within this subgroup was poor (r = 0.25-0.39). The median ROR score increased by increasing histological grade, but the ROR score ranges were wide (for G1 0-79, G2 0-90, G3 16-94). CONCLUSION: The Prosigna test result changed adjuvant treatment decisions in all EBC clinical risk groups, markedly decreased the CT use for patients categorized as higher clinical risk pre-Prosigna and reduced treatment decision discrepancies between hospitals.
Assuntos
Neoplasias da Mama , Humanos , Neoplasias da Mama/patologia , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/terapia , Feminino , Pessoa de Meia-Idade , Estudos Prospectivos , Quimioterapia Adjuvante/métodos , Idoso , Adulto , Linfonodos/patologia , Idoso de 80 Anos ou maisRESUMO
We report a 46-year-old male patient with retinocytoma who presented at the age of 31 asymptomatically. An intraocular retinal mass was incidentally found in his right eye, when he underwent ophthalmological assessment for refractive surgery. This tumor consisted of a calcified sessile basis partially covered by a pedunculated salmon-pink growth. Initially, the tumor was diagnosed as a retinocytoma with clinical suspicion of malignant transformation into retinoblastoma and treated by four sessions of laser photocoagulation. Six and a half years later, the tumor relapsed, and he was treated with a Ruthenium plaque. Following brachytherapy, he had two episodes of right-sided vitreous hemorrhage that spontaneously cleared up, and the remaining finding in the vitreous cavity was interpreted as asteroid hyalosis. He underwent vitrectomy about five years following brachytherapy. The analysis of the vitreous material revealed the presence of inactive vitreous seeds composed of small round blue cells, compatible with a type 2 regression.
RESUMO
Endocytosed Shiga toxin is transported from the Golgi complex to the endoplasmic reticulum in butyric acid-treated A431 cells. We here examine the extent of this retrograde transport and its regulation. The short B fragment of Shiga toxin is sufficient for transport to the ER. The B fragment of cholera toxin, which also binds to glycolipids, is transported to all the Golgi cisterns, but cannot be localized in the ER even after butyric acid treatment. Under all conditions the toxic protein ricin was found predominantly in the trans-Golgi network. There is no transport of endocytosed fluid to the Golgi apparatus or to the ER even after butyric acid treatment and in the presence of Shiga toxin, indicating that transport to the ER, through the trans-Golgi network and the cisterns of the Golgi apparatus, involves several sorting stations. Since Shiga toxin receptors (Gb3) in butyric acid-treated A431 cells seem to have a ceramide moiety with longer fatty acids than in untreated cells, the possibility exists that fatty acid composition of the receptor is important for sorting to the ER. Both retrograde transport and intoxication with Shiga toxin can also be induced by cAMP, supporting the idea that retrograde transport from the Golgi to the ER is required for intoxication. The data suggest that transport to the ER in cells in situ may depend on fatty acid composition and is regulated by physiological signals.
Assuntos
Toxinas Bacterianas/metabolismo , Butiratos/farmacologia , AMP Cíclico/farmacologia , Organelas/metabolismo , Fragmentos de Peptídeos/metabolismo , Toxinas Bacterianas/farmacologia , Transporte Biológico/efeitos dos fármacos , Ácido Butírico , Sequência de Carboidratos , Compartimento Celular , Toxina da Cólera/metabolismo , Toxina da Cólera/farmacologia , Relação Dose-Resposta a Droga , Interações Medicamentosas , Retículo Endoplasmático/metabolismo , Retículo Endoplasmático/ultraestrutura , Glicolipídeos/metabolismo , Complexo de Golgi/metabolismo , Complexo de Golgi/ultraestrutura , Peroxidase do Rábano Silvestre/metabolismo , Humanos , Dados de Sequência Molecular , Organelas/ultraestrutura , Ricina/metabolismo , Ricina/farmacologia , Toxinas Shiga , Triexosilceramidas/isolamento & purificação , Células Tumorais CultivadasRESUMO
Essentials The role of coagulation factor V (encoded by F5) in cancer pathogenesis is unknown. The clinical significance of tumor-expressed F5 was evaluated in breast cancer patient cohorts. F5 was expressed in human breast tumors, and the expression was higher than in normal tissue. High F5 expression was associated with aggressive tumors, but also with survival in breast cancer. SUMMARY: Background Tumor expression of certain coagulation factors has been linked to cancer progression. Single nucleotide polymorphisms (SNPs) in F5 (encoding the FV protein) have been found to be associated with breast cancer; however, the role of coagulation factor V (FV) in cancer pathogenesis remains undiscovered. Objectives We aimed to investigate the clinical significance of FV and the regulatory role of F5 gene variants in breast cancer. Patients/Methods A Scandinavian 503-sample breast cancer cohort and three public breast cancer datasets (GOBO, TCGA and KM plotter) were used to determine associations between F5 gene expression (tumor-specific), circulating FV, F5 SNPs, clinical characteristics and breast cancer survival. Immunohistochemistry (IHC) was used to detect FV antigen in tumors. Results F5 expression was 2-fold higher in breast tumors compared with normal tissue, and the presence of FV antigen in breast tumors was confirmed by IHC staining. F5 expression was increased in patients with hormone receptor negative tumors, triple negative tumors, HER2-enriched and basal-like tumors. In patients with basal tumors, high expression of F5 was associated with improved overall survival (hazard ratio, HR = 0.52, 95% confidence interval, 0.31-0.86). SNPs in F5 were associated with tumor size and luminal A tumors. The rs6427202-rs9332542 C-G haplotype, previously associated with breast cancer, displayed a cis-regulatory effect on F5 expression in tumors and plasma FV antigen levels. In silico mining supported this regulatory function. Conclusions FV was a possible marker of aggressive breast cancer, yet also a predictor of favorable outcome. Evaluation of FV expression may be clinically useful for prognosis and treatment decisions in aggressive breast cancer.
Assuntos
Biomarcadores Tumorais/genética , Neoplasias da Mama/genética , Fator V/genética , Polimorfismo de Nucleotídeo Único , Biomarcadores Tumorais/sangue , Neoplasias da Mama/sangue , Neoplasias da Mama/mortalidade , Neoplasias da Mama/patologia , Estudos Transversais , Bases de Dados Genéticas , Feminino , Regulação Neoplásica da Expressão Gênica , Predisposição Genética para Doença , Humanos , Imuno-Histoquímica , Metástase Linfática , Gradação de Tumores , Análise de Sequência com Séries de Oligonucleotídeos , Fenótipo , Prognóstico , Neoplasias de Mama Triplo Negativas/sangue , Neoplasias de Mama Triplo Negativas/genética , Neoplasias de Mama Triplo Negativas/mortalidade , Neoplasias de Mama Triplo Negativas/patologia , Carga Tumoral , Regulação para CimaRESUMO
The human epidermoid carcinoma cell line A431 becomes highly sensitive to Shiga toxin upon treatment with butyric acid. This strong sensitization (> 1000-fold) is accompanied by an increase in the fraction of cell-associated toxin transported to the Golgi apparatus and to the endoplasmic reticulum (ER). Furthermore, our previous work showed that the length of the fatty acyl chain of Gb3, the Shiga toxin receptor, also was changed (longer fatty acids). We have not investigated the importance of this change by testing whether glycolipid synthesis is required for the changed intracellular sorting and the toxin sensitivity. We demonstrate here that inhibition of glycosphingolipid synthesis by inhibition of N-acyltransferase with fumonisin B1, by inhibition of glucosylceramide synthetase by PDMP or PPMP, or by inhibition of serine palmitoyl transferase by beta-fluoroalanine, inhibited the butyric acid-induced change in sensitivity and the increase in the fraction of cell-associated Shiga toxin transported to the Golgi apparatus and the ER. The block in butyric acid-induced sensitization caused by beta-fluoroalanine could be abolished by simultaneous addition of sphinganine or sphingosine. Thus, the data suggest that the fatty acyl chain length of glycosphingolipids is important for intracellular sorting and translocation of Shiga toxin to the cytosol.
Assuntos
Toxinas Bacterianas/farmacologia , Butiratos/farmacologia , Carcinoma de Células Escamosas/metabolismo , Fumonisinas , Glicolipídeos/biossíntese , Aciltransferases/antagonistas & inibidores , Alanina/análogos & derivados , Alanina/farmacologia , Analgésicos Opioides/farmacologia , Antimetabólitos/farmacologia , Apoptose/efeitos dos fármacos , Toxinas Bacterianas/metabolismo , Toxinas Bacterianas/farmacocinética , Ácido Butírico , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/patologia , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/metabolismo , Inibidores Enzimáticos/farmacologia , Ácidos Graxos/química , Ácidos Graxos/metabolismo , Glucosiltransferases/antagonistas & inibidores , Glicolipídeos/química , Glicoesfingolipídeos/biossíntese , Glicoesfingolipídeos/química , Complexo de Golgi/efeitos dos fármacos , Complexo de Golgi/metabolismo , Peroxidase do Rábano Silvestre/efeitos dos fármacos , Peroxidase do Rábano Silvestre/metabolismo , Humanos , Concentração de Íons de Hidrogênio , Meperidina/análogos & derivados , Meperidina/farmacologia , Morfolinas/farmacologia , Micotoxinas/farmacologia , Receptores de Superfície Celular/efeitos dos fármacos , Receptores de Superfície Celular/metabolismo , Serina C-Palmitoiltransferase , Toxinas Shiga , Células Tumorais CultivadasRESUMO
The importance of cholesterol for endocytosis has been investigated in HEp-2 and other cell lines by using methyl-beta-cyclodextrin (MbetaCD) to selectively extract cholesterol from the plasma membrane. MbetaCD treatment strongly inhibited endocytosis of transferrin and EGF, whereas endocytosis of ricin was less affected. The inhibition of transferrin endocytosis was completely reversible. On removal of MbetaCD it was restored by continued incubation of the cells even in serum-free medium. The recovery in serum-free medium was inhibited by addition of lovastatin, which prevents cholesterol synthesis, but endocytosis recovered when a water-soluble form of cholesterol was added together with lovastatin. Electron microscopical studies of MbetaCD-treated HEp-2 cells revealed that typical invaginated caveolae were no longer present. Moreover, the invagination of clathrin-coated pits was strongly inhibited, resulting in accumulation of shallow coated pits. Quantitative immunogold labeling showed that transferrin receptors were concentrated in coated pits to the same degree (approximately sevenfold) after MbetaCD treatment as in control cells. Our results therefore indicate that although clathrin-independent (and caveolae-independent) endocytosis still operates after removal of cholesterol, cholesterol is essential for the formation of clathrin-coated endocytic vesicles.
Assuntos
Colesterol/fisiologia , Clatrina/fisiologia , Ciclodextrinas/farmacologia , Endocitose/fisiologia , Endossomos/fisiologia , Receptores da Transferrina/fisiologia , Transferrina/farmacocinética , beta-Ciclodextrinas , Animais , Linhagem Celular , Colesterol/isolamento & purificação , Clatrina/efeitos dos fármacos , Cães , Endocitose/efeitos dos fármacos , Endossomos/efeitos dos fármacos , Endossomos/ultraestrutura , Humanos , Rim , Cinética , Lipídeos de Membrana/fisiologia , Receptores da Transferrina/genética , Proteínas Recombinantes/metabolismo , Ricina/farmacocinética , Transfecção , Células Tumorais CultivadasRESUMO
In cells tested so far endocytosis seems to be dependent on N-ethylmaleimide (NEM)-sensitive proteins, and treatment with NEM results in a complete block of endocytosis. We here demonstrate that treatment of polarized MDCK I cells with NEM strongly increased endocytosis of ricin and horseradish peroxidase at the apical side, and electron microscopy revealed NEM-induced formation of large macropinosomes at the apical pole. The NEM-stimulated apical endocytosis seemed to involve phosphatidylinositol-3 kinase, protein kinase C and phospholipase D and it was dependent on ATP. Moreover, in contrast to endocytosis in nonpolarized cells ricin endocytosis at the basolateral side continued in the presence of NEM whereas endocytosis of transferrin was blocked. Furthermore, recycling of ricin endocytosed in the absence of NEM was not inhibited on either side upon addition of NEM demonstrating the existence of a NEM-resistant fusion machinery. The results suggest that the fusogenic property of both the apical and the basolateral plasma membrane of MDCK cells differs from that typically observed in cells unable to polarize.
Assuntos
Polaridade Celular/efeitos dos fármacos , Etilmaleimida/farmacologia , Pinocitose/fisiologia , Trifosfato de Adenosina/metabolismo , Androstadienos/farmacologia , Animais , Linhagem Celular , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Cromonas/farmacologia , Cães , Relação Dose-Resposta a Droga , Endocitose/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Galactose/metabolismo , Peroxidase do Rábano Silvestre/farmacocinética , Humanos , Microscopia Eletrônica , Morfolinas/farmacologia , Fosfatidilinositol 3-Quinases/metabolismo , Fosfolipase D/metabolismo , Pinocitose/efeitos dos fármacos , Proteína Quinase C/metabolismo , Ricina/farmacocinética , Fatores de Tempo , Células Tumorais Cultivadas , Wortmanina , terc-Butil Álcool/farmacologiaRESUMO
Bacterial toxins are associated with disease in humans and animals. Toxins can either be preformed in food or produced by bacteria in the intestine. There are two types of toxins: heat-labile protein toxins and heat stabile toxins. Heat labile toxins are produced by Bacillus cereus, Clostridium perfringens, Escherichia coli, and Vibrio cholerae, and heat-stabile enterotoxins consisting of relatively few amino acids are produced by Escherichia coli and acts by activation of guanylate cyclase. Similarly, heat-stabile entero-toxins are also produced by Staphylococcus aureus, a common cause of food poisoning in the United States, and Yersenia enterocolitica. Protein toxins produced by enteric bacteria can intoxicate intestinal cells and can also be taken up from the gut and reach other cells in the body. For example the Shiga-like toxins (vero-toxins) can intoxicate endothelial cells in the kidney and cause kidney failure. Intracellular transport and processing of a few of the protein toxins produced by enteric bacteria, namely Clostridium difficile toxin A and B, cholera toxin and the related heat-labile toxin produced by Escherichia coli, and Shiga toxin and Shiga-like toxins are presented.
Assuntos
Toxinas Bacterianas/metabolismo , Proteínas de Escherichia coli , Animais , Proteínas de Bactérias/metabolismo , Transporte Biológico , Membrana Celular/metabolismo , Toxina da Cólera/metabolismo , Clostridioides difficile , Endopeptidases/metabolismo , Enterotoxinas/metabolismo , Escherichia coli , Exotoxinas/metabolismo , Glicolipídeos/metabolismo , Humanos , Toxina Shiga I , Toxina Shiga II , Toxinas ShigaAssuntos
Toxinas Bacterianas/farmacologia , Inibidores Enzimáticos/farmacologia , Glicosídeo Hidrolases/antagonistas & inibidores , Shigella/metabolismo , Sequência de Aminoácidos , Animais , Toxinas Bacterianas/genética , Chlorocebus aethiops , Citotoxinas/genética , Citotoxinas/farmacologia , Escherichia coli/genética , Glicosídeo Hidrolases/química , Humanos , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Prolina/genética , Prolina/metabolismo , Serina/genética , Serina/metabolismo , Toxinas Shiga , Células Tumorais Cultivadas , Células VeroRESUMO
Cholera toxin is normally observed only in the Golgi apparatus and not in the endoplasmic reticulum (ER) although the enzymatically active A subunit of cholera toxin has a KDEL sequence. Here we demonstrate transport of horseradish peroxidase-labeled cholera toxin to the ER by electron microscopy in thapsigargin-treated A431 cells. Thapsigargin treatment strongly increased cholera toxin-induced cAMP production, and the formation of the catalytically active A1 fragment was somewhat increased. Binding of cholera toxin to the cell surface and transport of toxin to the Golgi apparatus were not changed in thapsigargin-treated cells, suggesting increased retrograde transport of cholera toxin from the Golgi apparatus to the ER. The data demonstrate that retrograde transport of cholera toxin can take place and that the transport is under regulation. The results are consistent with the idea that retrograde transport can be important for the action of cholera toxin.
Assuntos
Toxina da Cólera/metabolismo , Retículo Endoplasmático/metabolismo , Sinais Direcionadores de Proteínas , Tapsigargina/farmacologia , Cálcio/metabolismo , Carcinoma de Células Escamosas/metabolismo , AMP Cíclico/metabolismo , Complexo de Golgi/metabolismo , Humanos , Microscopia Eletrônica , Oligopeptídeos/metabolismo , Células Tumorais CultivadasRESUMO
Shiga toxin has a single A subunit non-covalently associated with a pentamer of B subunits. The toxin has a trypsin-sensitive region near the COOH-terminal end of the A-chain, and upon cleavage, two disulfide bonded fragments, A1 and A2, are generated. These fragments are also formed upon incubation with cells. The disulfide loop contains the sequence (Arg-X-X-Arg), which is a consensus motif for cleavage by the membrane-anchored protease furin. We found that a soluble form of furin cleaves intact A-chain producing A1 and A2 fragments, and furin also seems to be responsible for rapid cellular cleavage of Shiga toxin. LoVo cells, which normally do not produce functional furin, cleave intact A-chain very efficiently when transfected with furin (LoVo/fur), whereas a control cell (LoVo/neo) cleaves the toxin very slowly. To investigate the role of this cleavage for intoxication of cells, we studied the ability of unnicked and furin-nicked toxin to inhibit protein synthesis in LoVo/fur and LoVo/neo cells. LoVo/fur cells were intoxicated equally well with unnicked and nicked toxin, whereas in LoVo/neo cells nicked toxin was about 20 times more active than unnicked toxin. The results suggest that cleavage of Shiga toxin is important for intoxication of cells, and they indicate that furin can cleave and thereby activate Shiga toxin in cells.
Assuntos
Toxinas Bacterianas/metabolismo , Subtilisinas/metabolismo , Sequência de Aminoácidos , Animais , Toxinas Bacterianas/química , Toxinas Bacterianas/toxicidade , Butiratos/farmacologia , Ácido Butírico , Chlorocebus aethiops , Furina , Concentração de Íons de Hidrogênio , Dados de Sequência Molecular , Fragmentos de Peptídeos , Proteínas Recombinantes , Toxinas Shiga , Especificidade por Substrato , Células VeroRESUMO
Preincubation of Vero cells with 1 microM phorbol 12-myristate 13-acetate (PMA) decreased the specific binding of diphtheria toxin by about 50%, whereas the toxic effect, endocytic uptake and membrane translocation were completely blocked. Toxin bound to PMA-treated cells was released upon incubation with heparinase. The effect of PMA was abrogated in the presence of EDTA or N-(DL-[2-(hydroxyaminocarbonyl)methyl]-4-methyl-pentanoyl)-L-3-(2' - naphthyl)-alanyl-L-alanine 2-aminoethyl-amide (TAPI), a specific inhibitor of matrix metalloproteases. The results indicate that PMA induces proteolytic cleavage of the diphtheria-toxin receptor [heparin-binding EGF-like growth factor (HB-EGF)-precursor] outside the membrane anchor, and that about 50% of the growth-factor ecto-domain remains associated with the cells, due to binding to surface proteoglycans containing heparan sulphates. Although the cleaved cell-associated HB-EGF binds diphtheria toxin, it does not serve as a functional receptor, since neither toxin internalization nor translocation occurs. Thus the intact HB-EGF precursor is of crucial importance for its function as the diphtheria-toxin receptor.
Assuntos
Toxina Diftérica/metabolismo , Endocitose , Receptores de Superfície Celular/metabolismo , Animais , Transporte Biológico , Membrana Celular/metabolismo , Chlorocebus aethiops , Toxina Diftérica/antagonistas & inibidores , Endocitose/efeitos dos fármacos , Heparina Liase , Fator de Crescimento Semelhante a EGF de Ligação à Heparina , Hidrólise , Peptídeos e Proteínas de Sinalização Intercelular , Metaloendopeptidases/antagonistas & inibidores , Polissacarídeo-Liases/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Células VeroRESUMO
This paper studies the endocytosis of ricin at the apical pole of polarized MDCK II cells after permeabilization of the cells basolaterally with streptolysin O. Ricin endocytosis after the addition of cytosol with an ATP-regenerating system was 2-3-fold higher than after the addition of a transport medium. A similar increase in ricin endocytosis was obtained by reconstitution of dialyzed cytosol with the nonhydrolyzable GTP analog, GTP gamma S, in the presence of an ATP-regenerating system. The nonhydrolyzable GDP analog, GDP beta S, did not increase ricin uptake. In contrast to the data obtained with ricin, GTP gamma S was found to inhibit apical transferrin uptake in MDCK II cells transfected with the human transferrin receptor, and the data thus imply that GTP gamma S supports clathrin-independent endocytosis. Electron microscopy (EM) demonstrated that free endocytic vesicles were formed from the apical pole of permeabilized MDCK II cells in the presence of GTP gamma S and that both a ricin-HRP conjugate, HRP, and cationized gold were endocytosed. Ricin endocytosis in the presence of intact cytosol, as well as GTP gamma S-stimulated ricin uptake, was inhibited by Clostridium botulinum C3 transferase, an enzyme found to inactivate Rho proteins. The data demonstrate that apical clathrin-independent endocytosis functions in the presence of GTP gamma S, and suggest that one or more of the small GTP binding proteins of the Rho family is involved in regulation of the apical clathrin-independent endocytosis in MDCK II cells.
Assuntos
Toxinas Botulínicas , Polaridade Celular , Endocitose/fisiologia , Ricina/metabolismo , Proteínas rho de Ligação ao GTP/metabolismo , ADP Ribose Transferases/farmacologia , Animais , Proteínas de Bactérias , Linhagem Celular , Permeabilidade da Membrana Celular , Clatrina/metabolismo , Citoplasma/metabolismo , Cães , Endocitose/efeitos dos fármacos , Guanosina 5'-O-(3-Tiotrifosfato)/farmacologia , Guanosina Difosfato/análogos & derivados , Guanosina Difosfato/farmacologia , Humanos , Radioisótopos do Iodo/metabolismo , Rim , Cinética , Ensaio Radioligante , Estreptolisinas/farmacologia , Transferrina/metabolismo , Vesículas Transportadoras/metabolismo , Vesículas Transportadoras/ultraestrutura , Proteínas rho de Ligação ao GTP/antagonistas & inibidoresRESUMO
Shiga toxin consists of an enzymatically active A-chain and a pentameric binding subunit. The A-chain has a trypsin-sensitive region, and upon cleavage two disulfide bonded fragments, A1 and A2, are generated. To study the role of the disulfide bond, it was eliminated by mutating cysteine 242 to serine. In T47D cells this mutated toxin was more toxic than wild type toxin after a short incubation, whereas after longer incubation times wild type toxin was most toxic. Cells cleaved not only wild type but also mutated A-chain into A1 and A2 fragments. The mutated A-chain was more sensitive than wild type toxin to Pronase, and it was degraded at a higher rate in T47D cells. Subcellular fractionation demonstrated transport of both wild type and mutated toxin to the Golgi apparatus. Brefeldin A, which disrupts the Golgi apparatus, protected not only against Shiga toxin but also against the mutated toxin, indicating involvement of the Golgi apparatus. After prebinding of Shiga(C242S) toxin to wells coated with the Shiga toxin receptor, Gb3, trypsin treatment induced dissociation of A1 from the toxin-receptor complex demonstrating that in addition to stabilizing the A-chain, the disulfide bond prevents dissociation of the A1 fragment from the toxin-receptor complex.
Assuntos
Toxinas Bacterianas/metabolismo , Cisteína/metabolismo , Citotoxinas/metabolismo , Dissulfetos/metabolismo , Sequência de Aminoácidos , Transporte Biológico/efeitos dos fármacos , Transporte Biológico/genética , Brefeldina A , Ciclopentanos/farmacologia , Cisteína/genética , Relação Dose-Resposta a Droga , Feminino , Complexo de Golgi/metabolismo , Humanos , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Mutação Puntual , Conformação Proteica , Processamento de Proteína Pós-Traducional , Serina/genética , Serina/metabolismo , Toxinas Shiga , Testes de Toxicidade , Células Tumorais CultivadasRESUMO
Addition of arachidonic acid or stimulation of arachidonic acid production by secretory phospholipase A2 selectively upregulated apical endocytosis of ricin in MDCK cells without affecting basolateral endocytosis. Electron microscopic studies revealed that MDCK cells treated with secretory phospholipase A2 and incubated with horseradish peroxidase had an increased number of normal appearing peroxidase-labeled endosomes and no sign of membrane ruffling. Moreover, inhibition of basal arachidonic acid release, either by decreasing the cytosolic phospholipase A(2) activity or the diacylglycerol lipase activity, reduced the rate of apical endocytosis. Furthermore, indomethacin, an inhibitor of the cyclooxygenase pathway, counteracted the stimulation of endocytosis seen with both secretory phospholipase A2 and arachidonic acid, suggesting that formation of eicosanoids such as prostaglandins could be essential for the regulation. This idea was supported by the finding that prostaglandin E2, the predominant prostaglandin formed in kidney, also upregulated ricin uptake. The regulatory effect of the cyclooxygenase pathway on apical endocytosis of ricin was found to be independent of protein kinases A and C, which are known to selectively control apical clathrin-independent endocytosis in polarized cells.
Assuntos
Polaridade Celular/fisiologia , Endocitose/fisiologia , Prostaglandina-Endoperóxido Sintases/fisiologia , Ricina/metabolismo , Transdução de Sinais/fisiologia , Animais , Ácido Araquidônico/antagonistas & inibidores , Ácido Araquidônico/biossíntese , Ácido Araquidônico/metabolismo , Ácido Araquidônico/fisiologia , Ácidos Araquidônicos/farmacologia , Calcimicina/farmacologia , Linhagem Celular , Polaridade Celular/efeitos dos fármacos , Proteínas Quinases Dependentes de AMP Cíclico/fisiologia , Cicloexanonas/farmacologia , Inibidores de Ciclo-Oxigenase/farmacologia , Cães , Endocitose/efeitos dos fármacos , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Proteínas Heterotriméricas de Ligação ao GTP/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular , Ionomicina/farmacologia , Lipase Lipoproteica/antagonistas & inibidores , Inibidores de Lipoxigenase/farmacologia , Organofosfonatos , Peptídeos , Fosfolipases A/antagonistas & inibidores , Fosfolipases A/farmacologia , Fosfolipases A2 , Prostaglandinas/fisiologia , Proteína Quinase C/metabolismo , Transdução de Sinais/efeitos dos fármacos , Acetato de Tetradecanoilforbol/farmacologia , Venenos de Vespas/farmacologiaRESUMO
The effect of Shiga toxin with mutations in the A fragment has been tested on cells in order to get more information about the processing of the A fragment during entry into the cytosol. A mutant with a deletion between the A1 and A2 domain in the A fragment is resistant to cleavage by trypsin and is less toxic than wild type toxin on both Vero and A431 cells. The results support the view that processing of the A fragment is important for the high toxicity of the wild type toxin. A number of cell lines are resistant to Shiga toxin although they bind the toxin. However, A431 cells can be sensitized by butyric acid treatment, and transport of Shiga toxin to the Golgi apparatus seems to be required for the intoxication in the sensitized cells. The role of retrograde transport through the Golgi apparatus to the endoplasmic reticulum (ER) will be discussed.
Assuntos
Toxinas Bacterianas/farmacocinética , Sequência de Aminoácidos , Animais , Toxinas Bacterianas/genética , Transporte Biológico Ativo , Linhagem Celular , Retículo Endoplasmático/metabolismo , Complexo de Golgi/metabolismo , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Processamento de Proteína Pós-Traducional , Toxinas Shiga , Shigella/genética , Shigella/patogenicidadeRESUMO
Shiga toxin and some other protein toxins that act on targets in the cytosol have previously been shown to enter the trans-Golgi network. Transport by this route may be necessary for translocation of the toxin to the cytosol and for intoxication, but it is not known whether the enzymatically active part of the toxins actually enters the cytosol from the trans-Golgi network. It has been suggested that such toxins are transported in a retrograde manner to the endoplasmic reticulum and that translocation occurs in this organelle, but retrograde transport of endocytosed material beyond the trans-Golgi network has never been demonstrated. Here we show that in butyric acid-treated A431 cells endocytosed Shiga toxin is not only transported to the trans-Golgi network, but also to all Golgi stacks, to the endoplasmic reticulum and to the nuclear envelope. Furthermore, butyric acid sensitizes the cells to Shiga toxin, which is consistent with the possibility that retrograde transport is required for translocation of the toxin to the cytosol.
Assuntos
Proteínas de Bactérias/metabolismo , Toxinas Bacterianas/metabolismo , Retículo Endoplasmático/metabolismo , Proteínas de Bactérias/efeitos dos fármacos , Proteínas de Bactérias/ultraestrutura , Transporte Biológico/efeitos dos fármacos , Butiratos/farmacologia , Ácido Butírico , Endocitose , Complexo de Golgi/metabolismo , Humanos , Membrana Nuclear/metabolismo , Toxinas Shiga , Células Tumorais CultivadasRESUMO
The effect of calmodulin antagonists on endocytosis, transcytosis, recycling, and transport to the Golgi apparatus from both the apical and the basolateral plasma membrane of polarized Madin-Darby canine kidney cells has been investigated by using the plant toxin ricin as a membrane marker. The calmodulin antagonists trifluoperazine and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) stimulated apical endocytosis of ricin, whereas basolateral endocytosis was unaffected. A stimulation of the apical uptake of the fluid-phase marker horseradish peroxidase by calmodulin antagonists was also found both by biochemical and by ultrastructural studies. Furthermore, W-7 reduced the recycling of ricin to the apical plasma membrane, whereas the recycling to the basolateral plasma membrane was not changed. Transport of ricin to the Golgi apparatus was also selectively affected by the calmodulin antagonist W-7. After basolateral endocytosis of ricin, transport to the Golgi apparatus was reduced, whereas after apical endocytosis the fraction of endocytosed ricin transport to the Golgi apparatus was increased. Transcytosis of ricin from the basolateral to the apical pole was increased in the presence of calmodulin antagonists, whereas these compounds did not have any significant effect on the apical to basolateral transcytosis. Thus, the results obtained indicate that calmodulin is involved in regulation of apical endocytosis and recycling as well as in transcytosis of ricin from the basolateral plasma membrane. Furthermore, the data suggest that calmodulin plays a role in regulation of ricin transport to the Golgi apparatus.
Assuntos
Calmodulina/antagonistas & inibidores , Endocitose/efeitos dos fármacos , Ricina/metabolismo , Animais , Transporte Biológico/fisiologia , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina , Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Membrana Celular/metabolismo , Polaridade Celular/efeitos dos fármacos , Células Cultivadas/citologia , Células Cultivadas/enzimologia , Células Cultivadas/ultraestrutura , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Cães , Antagonistas de Dopamina/farmacologia , Complexo de Golgi/metabolismo , Peroxidase do Rábano Silvestre/farmacocinética , Imunoglobulina A/metabolismo , Radioisótopos do Iodo , Túbulos Renais Distais/citologia , Microscopia Eletrônica , Proteína Quinase C/metabolismo , Frações Subcelulares , Sulfonamidas/farmacologia , Trifluoperazina/farmacologia , Vasodilatadores/farmacologiaRESUMO
Cleavage of Shiga toxin A-fragment at a highly trypsin-sensitive site increases its enzymatic activity. To investigate the role of this cleavage site in intoxication of cells, we studied the routing, cleavage, and toxicity of mutant toxin where the trypsin-sensitive site had been eliminated. Ultrastructural analysis of toxin tagged with horseradish peroxidase demonstrated that wild-type and mutant toxins were transported from endosomes to the trans-Golgi network and further through the Golgi cisterns to the endoplasmic reticulum. Wild-type toxin was much more efficient than the mutants in provoking rapid intoxication, but after prolonged incubation time also mutants were highly toxic. The cells were able to cleave both wild-type Shiga toxin and the mutants, but the cellular location for cleavage appears to differ. Wild-type toxin was cleaved in the presence of brefeldin A, which disrupts the Golgi cisterns. This indicates that the cleavage occurs in the endosomes or in the trans-Golgi network. In contrast, the mutant Shiga-His (R248H/R251H) was not cleaved in the presence of brefeldin A, indicating that the cleavage can occur only after the toxin has left the trans-Golgi network. In vitro experiments showed that the cytosolic enzyme calpain is able to cleave Shiga-His, and results from in vivo experiments are consistent with the possibility that cleavage is carried out by calpain after the mutant A-fragment has reached the cytosol.